metaLead Therapeutics

Zurich, Switzerland Founded: 2022 • Age: 4 yrs
Next-generation medications against metal poisoning are developed.

About metaLead Therapeutics

metaLead Therapeutics is a company based in Zurich (Switzerland) founded in 2022 by Michal Shoshan.. metaLead Therapeutics has raised $170.02 thousand across 2 funding rounds from investors including Venture Kick.

  • Headquarter Zurich, Switzerland
  • Founders Michal Shoshan
  • Sectors
    Healthcare
  • Phone
    *********
Operational Areas
Healthcare → Medical Devices & Diagnostics
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $170.02 K (USD)

    in 2 rounds

  • Latest Funding Round
    $159.94 K (USD), Seed

    Mar 10, 2023

  • Investors
  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of metaLead Therapeutics

metaLead Therapeutics has successfully raised a total of $170.02K across 2 strategic funding rounds. The most recent funding activity was a Seed round of $159.94 thousand completed in March 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 2
  • Last Round Seed — $159,944
  • First Round

    (10 May 2022)

  • Investors Count 1
Date Amount Transaction Name Valuation Lead Investors Investors
Mar, 2023 Amount Seed - metaLead Therapeutics Valuation Venture Kick
May, 2022 Amount Seed - metaLead Therapeutics Valuation Venture Kick
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in metaLead Therapeutics

metaLead Therapeutics has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Venture Kick. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Investor Description Founded Year Domain Location
University backed startup accelerator
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by metaLead Therapeutics

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - metaLead Therapeutics

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Metalead Therapeutics Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of metaLead Therapeutics

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Metalead Therapeutics

Frequently Asked Questions about metaLead Therapeutics

When was metaLead Therapeutics founded?

metaLead Therapeutics was founded in 2022.

Where is metaLead Therapeutics located?

metaLead Therapeutics is headquartered in Zurich, Switzerland.

Is metaLead Therapeutics a funded company?

metaLead Therapeutics is a funded company, having raised a total of $170.02K across 2 funding rounds to date. The company's 1st funding round was a Seed of $10.07K, raised on May 10, 2022.

What does metaLead Therapeutics do?

MetaLead Therapeutics was founded in 2022 in Zurich, Switzerland, within the biotechnology sector. Focus is placed on developing treatments for metal poisoning, with operations centered on chelation therapy. The lead compound targets lead (Pb) toxicity, which remains the primary treatment approach. Research and development activities are conducted to advance therapeutic options for heavy metal exposures.

Who are metaLead Therapeutics's investors?

metaLead Therapeutics has 1 investor. Key investors include Venture Kick.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available